The Changing Financial Landscape of Renal Transplant Practice: A National Cohort Analysis

American Journal of Transplantation

Volumn 17, Issue 2, 2017, Pages 377-389

  Axelrod, D A ^a   Schnitzler, M A ^b   Xiao, H ^b   Naik, A S ^c   Segev, D L ^d   Dharnidharka, V R ^e   Brennan, D C ^e   Lentine, K L ^b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

business management; economics; health services and outcomes research; kidney transplantation nephrology; organ allocation; organ transplantation in general; recipient selection

Indexed keywords

CREATININE;

ADULT; AGE; ARTICLE; BLOOD COMPATIBILITY; CADAVER KIDNEY; CAUSE OF DEATH; COHORT ANALYSIS; FEMALE; FINANCIAL MANAGEMENT; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH CARE COST; HEART DEATH; HIGH RISK POPULATION; HOSPITALIZATION COST; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LINEAR REGRESSION ANALYSIS; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MEDICARE; OBESITY; POST TRANSPLANT SURVIVAL SCORE; PRIORITY JOURNAL; REIMBURSEMENT; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIZATION; UNIVARIATE ANALYSIS; CHRONIC KIDNEY FAILURE; CLINICAL PRACTICE; ECONOMICS; HISTOCOMPATIBILITY; PATIENT SELECTION; REGISTER; SUPPLY AND DISTRIBUTION; TRANSPLANTATION;

ADULT; AGE FACTORS; FEMALE; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; PATIENT SELECTION; PRACTICE PATTERNS, PHYSICIANS'; REGISTRIES; RETROSPECTIVE STUDIES; TISSUE AND ORGAN PROCUREMENT;

EID: 84994806889     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.14018     Document Type: Article

References (35)

1. Matas AJ, Smith JM, Skeans MA, et al. OPTN/SRTR 2013 Annual Data Report: Kidney. Am J Transplant 2015; 15(Suppl 2): 1–34.
2. Denecke C, Biebl M, Pratschke J. Optimizing clinical utilization and allocation of older kidneys. Curr Opin Organ Transplant 2015; 20: 431–437.
3. McAdams-DeMarco MA, Law A, King E, et al. Frailty and mortality in kidney transplant recipients. Am J Transplant 2015; 15: 149–154.
4. Rao PS, Merion RM, Ashby VB, Port FK, Wolfe RA, Kayler LK. Renal transplantation in elderly patients older than 70 years of age: Results from the Scientific Registry of Transplant Recipients. Transplantation 2007; 83: 1069–1074.
5. System USRD. Annual Data Report 2015 [cited 2016 Sept 8]. Available from: http://www.usrds.org/2015/view/Default.aspx.
6. Orandi BJ, Luo X, Massie AB, et al. Survival benefit with kidney transplants from HLA-incompatible live donors. N Engl J Med 2016; 374: 940–950.
7. Montgomery RA, Lonze BE, King KE, et al. Desensitization in HLA-incompatible kidney recipients and survival. N Engl J Med 2011; 365: 318–326.
8. Locke JE, Segev DL, Warren DS, Dominici F, Simpkins CE, Montgomery RA. Outcomes of kidneys from donors after cardiac death: Implications for allocation and preservation. Am J Transplant 2007; 7: 1797–1807.
9. Massie AB, Luo X, Chow EK, Alejo JL, Desai NM, Segev DL. Survival benefit of primary deceased donor transplantation with high-KDPI kidneys. Am J Transplant 2014; 14: 2310–2316.
10. Saidi RF, Elias N, Kawai T, et al. Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: Realities and costs. Am J Transplant 2007; 7: 2769–2774.
11. Buchanan PM, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR. Association of lower costs of pulsatile machine perfusion in renal transplantation from expanded criteria donors. Am J Transplant 2008; 8: 2391–2401.
12. Schnitzler MA, Lentine KL, Burroughs TE. The cost effectiveness of deceased organ donation. Transplantation 2005; 80: 1636–1637.
13. Matas AJ, Schnitzler M, Daar AS. Payment for living kidney donors (vendors) is not an abstract ethical discussion occurring in a vacuum. Am J Transplant 2004; 4: 1380–1381.
14. Held PJ, McCormick F, Ojo A, Roberts JP. A cost-benefit analysis of government compensation of kidney donors. Am J Transplant 2016; 16: 877–885.
15. Englesbe MJ, Ads Y, Cohn JA, et al. The effects of donor and recipient practices on transplant center finances. Am J Transplant 2008; 8: 586–592.
16. Axelrod DA. Economic and financial outcomes in transplantation: Whose dime is it anyway? Curr Opin Organ Transplant 2013; 18: 222–228.
17. Department of Health and Human Services. Health Resources and Services Administration. 2004 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1994-2003.
18. Axelrod DA, Dzebisashvili N, Lentine K, et al. Assessing variation in the costs of care among patients awaiting liver transplantation. Am J Transplant 2014; 14: 70–78.
19. Recipients SRoT. Technical methods for the program-specific reports. 2015 [cited 2016 Sept 8]. Available from: http://www.srtr.org/csr/current/Centers/201512/all_csr_documentation.pdf.
20. Nassir BA, Dean CE, Li S, et al. Variation in cost and quality in kidney transplantation. Transplantation 2015; 99: 2150–2157.
21. Whiting JF, Woodward RS, Zavala EY, et al. Economic cost of expanded criteria donors in cadaveric renal transplantation: Analysis of Medicare payments. Transplantation 2000; 70: 755–760.
22. Matas AJ, Schnitzler M. Payment for living donor (vendor) kidneys: A cost-effectiveness analysis. Am J Transplant 2004; 4: 216–221.
23. Gaylin DS, Held PJ, Port FK, et al. The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA 1993; 269: 603–608.
24. Huang E, Segev DL, Rabb H. Kidney transplantation in the elderly. Semin Nephrol 2009; 29: 621–635.
25. Schold JD, Srinivas TR, Howard RJ, Jamieson IR, Meier-Kriesche HU. The association of candidate mortality rates with kidney transplant outcomes and center performance evaluations. Transplantation 2008; 85: 1–6.
26. Schold JD, Meier-Kriesche HU. Which renal transplant candidates should accept marginal kidneys in exchange for a shorter waiting time on dialysis? Clin J Am Soc Nephrol 2006; 1: 532–538.
27. Heaphy EL, Poggio ED, Flechner SM, et al. Risk factors for retransplant kidney recipients: Relisting and outcomes from patients’ primary transplant. Am J Transplant 2014; 14: 1356–1367.
28. Schold JD, Buccini LD, Poggio ED, Flechner SM, Goldfarb DA. Association of candidate removals from the kidney transplant waiting list and center performance oversight. Am J Transplant 2016; 16: 1276–1284.
29. Vo AA, Petrozzino J, Yeung K, et al. Efficacy, outcomes, and cost-effectiveness of desensitization using IVIG and rituximab. Transplantation 2013; 95: 852–858.
30. Englesbe MJ, Dimick JB, Fan Z, Baser O, Birkmeyer JD. Case mix, quality and high-cost kidney transplant patients. Am J Transplant 2009; 9: 1108–1114.
31. Kutinova A, Woodward RS, Ricci JF, Brennan DC. The incidence and costs of sepsis and pneumonia before and after renal transplantation in the United States. Am J Transplant 2006; 6: 129–139.
32. Naik AS, Dharnidharka VR, Schnitzler MA, et al. Clinical and economic consequences of first-year urinary tract infections, sepsis, and pneumonia in contemporary kidney transplantation practice. Transpl Int 2016; 29: 241–252.
33. Woodward RS, Schnitzler MA, Baty J, et al. Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant 2003; 3: 590–598.
34. Schnitzler MA, Johnston K, Axelrod D, Gheorghian A, Lentine KL. Associations of renal function at 1-year after kidney transplantation with subsequent return to dialysis, mortality, and healthcare costs. Transplantation 2011; 91: 1347–1356.
35. Gheorghian A, Schnitzler MA, Axelrod DA, Kalsekar A, L'Italien G, Lentine KL. The implications of acute rejection and reduced allograft function on health care expenditures in contemporary US kidney transplantation. Transplantation 2012; 94: 241–249.